Local 12: Trial looks at treating pneumonia associated with COVID-19
Study examines anti-viral medication that could help reduce common complication of the coronavirus
A breakthrough trial is looking at a new anti-viral medication that could help reduce one of the most common complications of the COVID-19 coronavirus: pneumonia.
This new trial is one of a handful across the country looking at an antiviral therapy intended to stop the spread of this virus.
A team at the University of Cincinnati is conducting this research. Brett Kissela, MD, senior associate dean of clinical research at the UC College of Medicine and UC Health physician, is featured.
Read more about UC-led clinical trials.
Featured photo/Colleen Kelley/UC Creative + Brand
Related Stories
Medical devices exec touts UC co-op
October 15, 2026
UC College of Engineering and Applied Science alumnus Adam Hauke talks to Medium about the speed of innovation in developing new medical devices. Hauke is global director of product strategy & innovation at Gentherm Medical. He earned a doctorate and bachelor's degree in biomedical engineering from UC.
UC Med Mentors welcomes 39 new mentees at match event
October 15, 2026
University of Cincinnati College of Medicine medical students matched with 39 Oyler School mentees at a UC Med Mentors match event, beginning four-year mentoring relationships.
What does Kroger's restructuring mean for Cincinnati?
October 15, 2026
Two UC economists spoke to WLWT on what Kroger's planned job cuts mean for the company and the community where it's headquartered.